Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KX8B
|
|||
| Former ID |
DIB009618
|
|||
| Drug Name |
GNE Lipoplex
|
|||
| Synonyms |
GNE Lipoplex (intramuscular, HIBM-2)
Click to Show/Hide
|
|||
| Indication | Myopathy [ICD-11: 8C7Y] | Phase 1 | [1] | |
| Company |
Gradalis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-acetylmannosamine kinase (GNE) | Target Info | Inhibitor | [2] |
| BioCyc | CMP-N-acetylneuraminate biosynthesis I (eukaryotes) | |||
| KEGG Pathway | Amino sugar and nucleotide sugar metabolism | |||
| Metabolic pathways | ||||
| Pathwhiz Pathway | Amino Sugar Metabolism | |||
| Reactome | Sialic acid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034673) | |||
| REF 2 | Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. Hum Gene Ther. 2011 Nov;22(11):1331-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.